Bleeding
| Bleeding | Assess whether bleeding is spontaneous, or inappropriate and/or excessive in relation to trauma. Note site and nature of bleeding; presence and duration of previous history of surgical, dental, joint, menstrual, mucosal, and skin bleeding; presence of underlying disorder, or use of drugs associated with risk of bleeding. Laboratory testing if indicated; see Figure 1 . See also Bruising , Purpura . |
| Acquired bleeding disorders | Initially - FBC , blood film , platelet count . Additional tests as indicated by the clinical context; see below. |
| Advanced and/or metastatic carcinoma | See under Carcinoma . |
| Blood transfusion related DIC |
See under Blood transfusion . |
| Drug-related bleeding | |
| Anticoagulant therapy | See Anticoagulant monitoring . |
| Fibrinolytic therapy | See Thrombolytic therapy . |
| Aspirin, other NSAID | Predictable abnormality of bleeding time and platelet aggregation; these tests do not predict the risk of bleeding and are not indicated. |
| Thrombocytopenia | |
| Liver disease | See Bleeding under Cirrhosis - consequences. |
| Multiple myeloma | |
| Myeloproliferative disorders esp | |
| Essential Thrombocythaemia
Myelofibrosis |
|
| Neonatal bleeding | |
| Obstetric (peripartum) bleeding | See under Pregnancy . |
| Paraproteinaemia | |
| Renal failure | See Bleeding under Renal failure - chronic (complications). |
| Rodenticide poisoning | See under Poisoning . |
| SLE | |
| Thrombocytopenia | |
| Inherited bleeding disorders |
There is usually a personal and/or family history of bleeding. Mild disorders may present as surgical or dental bleeding in the adult. Initially - FBC , platelet count , blood film ; PT , APTT . Normal results do not exclude the possibility of a clinically significant inherited bleeding disorder and further investigation should be determined on the basis of the history. The bleeding time has little place in this initial assessment; consult pathologist. Further tests as indicated from the initial results, and as appropriate to the history and the degree of clinical suspicion. See Figure 1 . |
| von Willebrands disease | |
| Haemophilia A | See under Haemophilia . |
| Haemophilia B | See under Haemophilia . |
| Factor XI deficiency | Coagulation factors (XI) assay. |
| Factor XII deficiency | Coagulation factors (XII) assay; this deficiency is not associated with an increased risk of bleeding. |
| Factor XIII deficiency | Factor XIII screening test; consult pathologist. |
| Hypofibrinogenaemia/ afibrinogenaemia | Thrombin time , fibrinogen assay . |
| Dysfibrinogenaemia | Thrombin time , reptilase time ; consult pathologist. |
| Other inherited coagulation disorders | Rare; consult pathologist. |
| Inherited disorders of platelet function | A normal bleeding time does not exclude a clinically significant disorder of platelet function. |
| Release disorders eg | Platelet aggregation/release studies. For definitive platelet membrane, granule, and prostaglandin studies - consult pathologist. |
| Storage pool disease | |
| Thrombasthenia | |
| Bernard Soulier syndrome | |
| Hereditary haemorrhagic telangiectasia | Clinical diagnosis. Mucocutaneous telangiectases with recurrent bleeding from mucosal surfaces. See also Telangiectases . |
| Collagen disorders | The bleeding time may be prolonged. |